Leena Nahata1,2,3, Taylor L Morgan1, Keagan G Lipak1, Olivia E Clark1, Nicholas D Yeager3,4, Sarah H O'Brien3,4,5, Stacy Whiteside4, Anthony Audino3,4, Gwendolyn P Quinn6, Cynthia A Gerhardt1,3. 1. Center for Biobehavioral Health, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio. 2. Divisions of Endocrinology, Nationwide Children's Hospital, Columbus, Ohio. 3. The Ohio State University College of Medicine, Columbus, Ohio. 4. Hematology/Oncology, Nationwide Children's Hospital, Columbus, Ohio. 5. Center for Innovation and Pediatric Practice, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio. 6. Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York.
Abstract
BACKGROUND: Over half of male childhood cancer survivors experience infertility after treatment, which is known to cause distress and impact future quality of life. Sperm banking rates remain low, and little is known about how adolescent and young adult (AYA) males and their families make fertility preservation (FP) decisions. This study examined AYA and parent perceptions of participating in a research study focused on testing a new FP decision tool at the time of cancer diagnosis. METHODS: Forty-four participants (19 mothers, 11 fathers, 14 male AYAs 12-25 years old) from 20 families completed brief assessments at diagnosis and approximately one month later, including a qualitative interview exploring the impact of study participation. Verbatim transcripts were coded through thematic content analysis using the constant comparison method. RESULTS: Two major themes emerged: (1) a positive effect of participating in the study and (2) a neutral effect (no positive/negative effect of participation). Subthemes that emerged for participants who noted a positive effect included (a) participation prompted deeper thinking, (b) participation influenced family conversations, and (c) participation resulted in altruism/helping others. No participant reported a negative effect. CONCLUSIONS: This study demonstrates that participation in family-centered research focused on FP among AYA males, before treatment begins, is perceived as beneficial or neutral at the time of a new cancer diagnosis. These findings provide support for future family-centered FP interventions for this population.
BACKGROUND: Over half of male childhood cancer survivors experience infertility after treatment, which is known to cause distress and impact future quality of life. Sperm banking rates remain low, and little is known about how adolescent and young adult (AYA) males and their families make fertility preservation (FP) decisions. This study examined AYA and parent perceptions of participating in a research study focused on testing a new FP decision tool at the time of cancer diagnosis. METHODS: Forty-four participants (19 mothers, 11 fathers, 14 male AYAs 12-25 years old) from 20 families completed brief assessments at diagnosis and approximately one month later, including a qualitative interview exploring the impact of study participation. Verbatim transcripts were coded through thematic content analysis using the constant comparison method. RESULTS: Two major themes emerged: (1) a positive effect of participating in the study and (2) a neutral effect (no positive/negative effect of participation). Subthemes that emerged for participants who noted a positive effect included (a) participation prompted deeper thinking, (b) participation influenced family conversations, and (c) participation resulted in altruism/helping others. No participant reported a negative effect. CONCLUSIONS: This study demonstrates that participation in family-centered research focused on FP among AYA males, before treatment begins, is perceived as beneficial or neutral at the time of a new cancer diagnosis. These findings provide support for future family-centered FP interventions for this population.
Authors: Martine C de Vries; Dorine Bresters; Dirk P Engberts; Jan M Wit; Evert van Leeuwen Journal: Pediatr Blood Cancer Date: 2009-09 Impact factor: 3.167
Authors: James L Klosky; Jessica S Flynn; Vicky Lehmann; Kathryn M Russell; Fang Wang; Robin N Hardin; Jasmine R Eddinger; Hui Zhang; Lauren A-M Schenck; Leslie R Schover Journal: Fertil Steril Date: 2017-12 Impact factor: 7.329
Authors: Daniel M Green; Toana Kawashima; Marilyn Stovall; Wendy Leisenring; Charles A Sklar; Ann C Mertens; Sarah S Donaldson; Julianne Byrne; Leslie L Robison Journal: J Clin Oncol Date: 2009-11-30 Impact factor: 44.544
Authors: James L Klosky; Fang Wang; Kathryn M Russell; Hui Zhang; Jessica S Flynn; Lu Huang; Karen Wasilewski-Masker; Wendy Landier; Marcia Leonard; Karen H Albritton; Abha A Gupta; Jacqueline Casillas; Paul Colte; William H Kutteh; Leslie R Schover Journal: J Clin Oncol Date: 2017-10-04 Impact factor: 44.544
Authors: M Peate; B Meiser; B C Cheah; C Saunders; P Butow; B Thewes; R Hart; K-A Phillips; M Hickey; M Friedlander Journal: Br J Cancer Date: 2012-03-13 Impact factor: 7.640
Authors: Taylor L Morgan; Braedon P Young; Keagan G Lipak; Vicky Lehmann; James Klosky; Gwendolyn P Quinn; Cynthia A Gerhardt; Leena Nahata Journal: J Adolesc Young Adult Oncol Date: 2020-04-22 Impact factor: 2.223
Authors: Leena Nahata; Antoinette Anazodo; Brooke Cherven; Shanna Logan; Lillian R Meacham; Cathy D Meade; Sara Zarnegar-Lumley; Gwendolyn P Quinn Journal: Pediatr Blood Cancer Date: 2020-07-06 Impact factor: 3.167
Authors: John M Salsman; Betina Yanez; Mallory A Snyder; Alexis R Avina; Marla L Clayman; Kristin N Smith; Khouri Purnell; David Victorson Journal: Support Care Cancer Date: 2021-03-25 Impact factor: 3.359
Authors: Leena Nahata; Taylor M Dattilo; Anna L Olsavsky; Keagan G Lipak; Stacy Whiteside; Nicholas D Yeager; Anthony Audino; James L Klosky; Joseph Rausch; Amanda Saraf; Sarah H O'Brien; Gwendolyn P Quinn; Cynthia A Gerhardt Journal: J Assist Reprod Genet Date: 2021-02-10 Impact factor: 3.357
Authors: Charleen I Theroux; Kylie N Hill; Anna L Olsavsky; James L Klosky; Nicholas D Yeager; Anthony Audino; Sarah H O'Brien; Gwendolyn P Quinn; Cynthia A Gerhardt; Leena Nahata Journal: Cancers (Basel) Date: 2021-07-16 Impact factor: 6.639